New Age Farm

Core One Labs, formerly known as New Age Farm, is a Canadian life sciences company focused on the development of psychedelic-based therapies and innovative drug delivery systems. The company specializes in the biosynthetic production of pharmaceutical-grade psilocybin and the engineering of proprietary delivery methods, such as sublingual thin film strips, to enhance the bioavailability and precision of psychedelic treatments. Through its subsidiaries, including Vocan Biotechnologies and Akome Biotech, Core One Labs is advancing a pipeline of psychedelic formulations targeting mental health and neurological conditions such as major depressive disorder, anxiety, and addiction. The company's business model integrates drug discovery, delivery technology, and clinical research to provide more effective therapeutic options for patients with unmet needs. Core One Labs is publicly traded on the Canadian Securities Exchange and continues to expand its intellectual property portfolio in the psychedelic medicine space.